245 related articles for article (PubMed ID: 2786749)
21. Interleukin 1 gene expression in adult T cell leukemia.
Wano Y; Hattori T; Matsuoka M; Takatsuki K; Chua AO; Gubler U; Greene WC
J Clin Invest; 1987 Sep; 80(3):911-6. PubMed ID: 2887587
[TBL] [Abstract][Full Text] [Related]
22. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response.
Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H
J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
[TBL] [Abstract][Full Text] [Related]
25. Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors.
Hogge DE; Yalcintepe L; Wong SH; Gerhard B; Frankel AE
Clin Cancer Res; 2006 Feb; 12(4):1284-91. PubMed ID: 16489085
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cells.
Sweeney EB; Foss FM; Murphy JR; vanderSpek JC
Bioconjug Chem; 1998; 9(2):201-7. PubMed ID: 9548535
[TBL] [Abstract][Full Text] [Related]
27. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.
Okada M; Maeda M; Tagaya Y; Taniguchi Y; Teshigawara K; Yoshiki T; Diamantstein T; Smith KA; Uchiyama T; Honjo T
J Immunol; 1985 Dec; 135(6):3995-4003. PubMed ID: 2999237
[TBL] [Abstract][Full Text] [Related]
28. [Immunological characterizations of adult T cell leukemia cells].
Hattori T
Rinsho Ketsueki; 1989 Oct; 30(10):1738-43. PubMed ID: 2593239
[TBL] [Abstract][Full Text] [Related]
29. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.
Waldmann TA; Goldman CK
Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):45-53. PubMed ID: 2683757
[TBL] [Abstract][Full Text] [Related]
30. IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy.
Waldmann TA
Cancer Surv; 1989; 8(4):891-903. PubMed ID: 2701734
[TBL] [Abstract][Full Text] [Related]
31. Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation.
Walz G; Zanker B; Brand K; Waters C; Genbauffe F; Zeldis JB; Murphy JR; Strom TB
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9485-8. PubMed ID: 2594781
[TBL] [Abstract][Full Text] [Related]
32. A kinetic analysis of the effects of interleukin-2 diphtheria toxin fusion protein upon activated T cells.
Walz G; Zanker B; Murphy JR; Strom TB
Transplantation; 1990 Jan; 49(1):198-201. PubMed ID: 2301012
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
Bacha P; Williams DP; Waters C; Williams JM; Murphy JR; Strom TB
J Exp Med; 1988 Feb; 167(2):612-22. PubMed ID: 3126255
[TBL] [Abstract][Full Text] [Related]
34. Autocrine stimulation of interleukin 1 alpha in the growth of adult human T-cell leukemia cells.
Shirakawa F; Tanaka Y; Oda S; Eto S; Yamashita U
Cancer Res; 1989 Mar; 49(5):1143-7. PubMed ID: 2783884
[TBL] [Abstract][Full Text] [Related]
35. Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.
Potala S; Verma RS
J Biotechnol; 2010 Jul; 148(2-3):147-55. PubMed ID: 20580754
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study on the serum carcinoembryonic antigen, immunosuppressive acidic protein and C-reactive protein levels in patients with adult T cell leukemia].
Kumagai E; Ogata M; Maeda Y; Kumagai T; Okajima K; Yamaguchi K; Tanoue S
Rinsho Byori; 1989 Jul; 37(7):769-73. PubMed ID: 2607647
[TBL] [Abstract][Full Text] [Related]
37. [Relationship of diffuse panbronchiolitis (DPB) and idiopathic interstitial pneumonia (IIP) with adult T cell leukemia (ATL)].
Tsubota T; Tada S
Rinsho Ketsueki; 1989 Oct; 30(10):1723-31. PubMed ID: 2624659
[TBL] [Abstract][Full Text] [Related]
38. [Urinary excretion of parathyroid hormone-related protein in patients with adult T-cell leukemia and other hematologic disorders].
Mori N; Ohsumi K; Murakami S; Wake A; Nakata K; Misago M; Oda S; Eto S
Rinsho Ketsueki; 1992 Sep; 33(9):1158-65. PubMed ID: 1433936
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-2 receptor targeted therapy of ocular disease of HTLV-1-associated adult T-cell leukemia.
Larson TA; Hu M; Janik JE; Nussenblatt RB; Morris JC; Sen HN
Ocul Immunol Inflamm; 2012 Aug; 20(4):312-4. PubMed ID: 22642512
[TBL] [Abstract][Full Text] [Related]
40. Characterization and regulation of interleukin-4 receptor in adult T-cell leukemia cells.
Mori N; Shirakawa F; Murakami S; Oda S; Eto S
Eur J Haematol; 1996 Apr; 56(4):241-7. PubMed ID: 8641393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
